How to assess vascular remodelling in small and medium-sized muscular arteries in humans

Journal of Hypertension

Volumn 15, Issue 6, 1997, Pages 571-584

  Schiffrin, Ernesto L ^a   Hayoz, Daniel ^b  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Arterial wall mechanics; Blood pressure; Echo tracking; Hypertension; Resistance arteries; Smooth muscle; Ultrasound; Wire myograph

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTERY DIAMETER; ARTERY WALL; CAPILLARY; HUMAN; HYPERTENSION; PRIORITY JOURNAL; REVIEW;

EID: 0030979759     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199715060-00002     Document Type: Review

References (112)

1. Folkow B: Physiological aspects of primary hypertension. Physiol Rev 1982, 62:347-504.
2. Mulvany MJ, Aalkjær C: Structure and function of small arteries. Physiol Rev 1990, 70:921-971.
3. Schiffrin EL: Reactivity of small blood vessels in hypertension. Relationship with structural changes. Hypertension 1992, 19 (suppl II:II1-II9.
4. Heagerty AM, Aalkjær C, Bund SJ, Korsgaard N, Mulvany MJ: Small artery structure in hypertension: dual processes of remodelling and growth. Hypertension 1993, 21:391-397.
5. Chobanian A: Adaptive and maladaptive responses of the arterial wall to hypertension. Hypertension 1990, 15:666-674.
6. Hayoz D, Rutschmann B, Perret F, Niederberger M, Tardy Y, Mooser V, et al.: Conduit artery compliance and distensibility are not necessarily reduced in hypertension. Hypertension 1992, 20:1-6.
7. Christensen KL, Mulvany MJ: Mesenteric arcade arteries contribute substantially to vascular resistance in conscious rats. J Vasc Res 1993, 30:73-79.
8. Folkow B: Hypertensive structural changes in systemic precapillary resistance vessels: how important are they for in vivo haemodynamics? J Hypertens 1995, 13:1546-1559.
9. Izzard AS, Heagerty AM: Hypertension and the vasculature: arterioles and the myogenic response. J Hypertens 1995, 13:1-4.
10. Spence JD: Cerebral consequences of hypertension. In Hypertension, Pathophysiology, Diagnosis and Management. Second Edition, Edited by Laragh JH, Brenner BM. New York: Raven Press Ltd; 1995:741-753.
11. Ruilope LM, Alc{{ä}}zar JM, Rodicio JL: Renal consequences of hypertension. J Hypertens 1992, 10 (suppl 7):S85-S90.
12. Brush JE, Cannon RO, Schenke WH, Bonow RO, Leon MB, Maron BJ, et al.: Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 1988, 319:1302-1307.
13. Fuster V, Badimon L, Badimon JJ, Chesebro JH: The pathogenesis of acute coronary syndromes. N Engl J Med 1992, 326:242-250, 310-318.
14. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension, II: results in patients with diastolic blood pressure averaging 90 through 114 mmHg. JAMA 1970, 202:1143-1152.
15. Australian National Blood Pressure Study Management Committee: Australian Therapeutic Trial in Mild Hypertension. Lancet 1980, i:1262-1267.
16. Hypertension Detection and Follow-up Program Cooperative Group: The effect of treatment on mortality in mild hypertension, N Engl J Med 1982, 307:976-980.
17. Medical Research Council Working Party: MRC trial of treatment of mild hypertension: principal results. BMJ 1985, 291:97-104.
18. Medical Research Council Working Party: MRC trial of treatment of hypertension in older adults: principal results. BMJ 1992, 304:405-412.
19. Schiffrin EL, Deng LY, Larochelle P: Effects of a beta blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 1994, 23:83-91.
20. Schiffrin EL, Deng LY, Larochelle P: Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor. Comparison with effects of a beta blocker. Am J Hypertens 1995, 8:229-236.
21. Thybo NK, Stephens N, Cooper A, Aalkjær C, Heagerty AM, Mulvany MJ: Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995, 25:474-481.
22. Schiffrin EL, Deng LY: Comparison of effects of angiotensin I-converting enzyme inhibition and beta blockade on function of small arteries from hypertensive patients. Hypertension 1995, 25:699-703.
23. Thybo NK, Korsgaard N, Eriksen S, Christensen KL, Mulvany MJ: Dose-dependent effects of perindopril on blood pressure and small-artery structure. Hypertension 1994, 23:659-666.
24. Li J-S, Schiffrin EL: Effect of calcium channel blockade or angiotensin converting enzyme inhibition on structure of coronary, renal and other small arteries in SHR. J Cardiovasc Pharmacol 1996, 28: 68-74.
25. Goode GK, Heagerty AM: In vitro responses of human peripheral small arteries in hypercholesterolemia and effects of therapy. Circulation 1996, 91:2898-2903.
26. Simon AC, Levenson J, Bouthier JD, Benetos A, Safar ME: Post-synaptic alpha blockade and brachial artery compliance in essential hypertension. J Hypertens 1984, 2:37-41.
27. Simon AC, Levenson J, Bouthier JD, Safar ME: Effects of chronic administration of enalapril and propranolol on large arteries in essential hypertension. J Cardiovasc Pharmacol 1985, 7: 856-861.
28. Levy BI, Poitevin P, Safar ME: Effects of indapamide on the mechanical properties of the arterial wall in desoxycorticosterone acetate-salt hypertensive rats. J Cardiovasc Pharmacol 1989, 14:28H-32H.
29. Schiffrin EL: Vascular structure in L-NAME-induced hypertension: methodological considerations for studies of small arteries in hypertension. J Hypertens 1995, 13:817-821.
30. Baumbach GL, Heistad DD: Remodelling of cerebral arterioles in chronic hypertension. Hypertension 1989, 13:968-972.
31. Hajdu MA, Baumbach GL: Mechanics of large and small cerebral arteries in chronic hypertension. Am J Physiol 1994, 266:H1027-H1033.
32. Mulvany MJ, Baumbach GL, Aalkjær C, Heagerty AM, Korsgaard N, Schiffrin EL, et al.: Vascular remodelling [letter]. Hypertension 1996, 28:505-506.
33. Korner PI, Angus JA: Vascular remodelling [commentary]. Hypertension 1997, 29:1065-1066.
34. Lee RMKW, Adams MA, Friberg P, Hamet P, Smeda J: Comments on vascular remodelling. J Hypertens 1997, 15:333.
35. Mulvany MJ, Baumbach GL, Aalkjær C, Heagerty AM, Korsgaard N, Schiffrin EL, et al.: Response. J Hypertens 1997, 15:334.
36. Folkow B: Comments on vascular remodelling. J Hypertens 1997, 15: 335.
37. Essex TJH, Byrne PO: A laser Doppler scanner for imaging blood flow in skin. J Biomed Eng 1991, 13:189-194.
38. Wenzel RR, Noll G, Lüscher TF: Endothelin receptor antagonists inhibit endothelin in human skin microcirculation. Hypertension 1994, 23:581-586.
39. Gasser P, Bühler FR: Nailfold microcirculation in normotensive and essential hypertensive subjects, as assessed by video-microscopy. J Hypertens 1992, 10:83-86.
40. Draaijer P, de Leeuw PW, van Hooff JP, Leunissen KM: Nailfold capillary density in salt-sensitive and salt-resistant borderline hypertension. J Hypertens 1993, 11:1195-1198.
41. Prasad A, Dunnill GS, Mortimer PS, MacGregor GA: Capillary rarefaction in the forearm skin in essential hypertension. J Hypertens 1995, 13:265-268.
42. Stanton AV, Mullaney P, Mee F, O'Brien ET, O'Malley K: A method of quantifying retinal microvascular alterations associated with blood pressure and age. J Hypertens 1995, 13:41-48.
43. Houben AJHM, Canoy MCW, Paling HA, Derhaag PJFM, de Leeuw PW: Quantitative analysis of retinal vascular changes in essential and renovascular hypertension. J Hypertens 1995, 13:1729-1733.
44. Agabiti Rosei E, Rizzoni D, Castellano M, Porteri E, Zulli R, Muiesan ML, et al.: Media:lumen ratio in human small resistance arteries is related to forearm minimal vascular resistance. J Hypertens 1995, 13:341-349.
45. Aalkjær C, Heagerty AM, Petersen KK, Swales JD, Mulvany MJ: Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res 1987, 61:181-186.
46. Korsgaard N, Aalkjær C, Heagerty AM, Izzard AS, Mulvany MJ: Histology of subcutaneous small arteries from patients with essential hypertension. Hypertension 1993, 22:523-526.
47. Schiffrin EL, Deng LY, Larochelle P: Morphology of resistance arteries and comparison of effects of vasoconstrictors in mild essential hypertensive patients. Clin Invest Med 1993, 16:177-186.
48. Schiffrin EL, Deng LY: Structure and function of resistance arteries of hypertensive patients treated with a beta blocker or a calcium channel antagonist. J Hypertens 1996, 14:1247-1255.
49. Schiffrin EL: Effect of antihypertensive therapy on small artery structure in hypertensive patients [letter]. Hypertension 1995, 26:716-717.
50. Mulvany MJ: Effect of antihypertensive therapy on small artery structure in hypertensive patients [Response]. Hypertension 1995, 26:717-718.
51. Bevan JA, Osher JV: A direct method for recording tension changes in the wall of small blood vessels in vitro. Agents Actions 1972, 2:257-260.
52. Mulvany MJ, Halpern W: Mechanical properties of vascular smooth muscle cells in situ. Nature 1976, 260:617-619.
53. Mulvany MJ, Halpern W: Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977, 41:19-26.
54. Halpern W, Mulvany MJ, Warshaw DM: Mechanical properties of smooth muscle cells in the walls of arterial resistance vessels. J Physiol 1978, 275:85-101.
55. Mulvany MJ, Hansen PK, Aalkjær C: Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cells layers. Circ Res 1978, 43:854-864.
56. Halpern W, Osol G, Coy GS: Mechanical behaviour of pressurized in vitro prearteriolar vessels determined with a video system. Ann Biomed Eng 1984, 12:463-479.
57. Dunn WR, Gardiner SM: No evidence for vascular remodelling during hypertension induced by chronic inhibition of nitric oxide synthase in Brattleboro rats. J Hypertens 1995, 13:849-857.
58. Mulvany MJ, Korsgaard N: Correlations and otherwise between blood pressure, cardiac mass and resistance vessel characteristics in hypertensive, normotensive and hypertensive/normotensive hybrid rats. J Hypertens 1983, 1:235-244.
59. Christensen KL, Jespersen LT, Mulvany MJ: Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure. J Hypertens 1989, 7:83-90.
60. Thybo NK, Mulvany MJ, Jastrup B, Nielsen H, Aalkjær C: Some pharmacological and elastic characteristics of isolated subcutaneous small arteries from patients with essential hypertension. J Hypertens 1996, 14:993-998.
61. Deng LY, Schiffrin EL: Effects of endothelin on resistance arteries of DOCA-salt hypertensive rats. Am J Physiol 1992, 262:H1782-H1787.
62. Deng LY, Schiffrin EL: Effects of endothelin-1 and vasopressin on resistance arteries of spontaneously hypertensive rats. Am J Hypertens 1992, 5:817-822.
63. Griffin SA, Brown WCB, MacPherson F, McGrath JC, Wilson VG, Korsgaard N, et al.: Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 1991, 17: 626-635.
64. Harrap SB, Van der Merwe WM, Griffin SA, MacPherson F, Level AF: Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension 1990, 16:603-614.
65. Morton JJ, Beattie EC, MacPherson F: Angiotensin II receptor antagonist losartan has persistent effects on blood pressure in the young spontaneously hypertensive rats: lack of relation to vascular structure. J Vasc Res 1992, 29:264-269.
66. Boonen HCM, Daemen MJAP, Eerdmans PHA, Fazzi GE, van Kleef EM, Schiffers PMH, et al.: Mesenteric small artery changes after vasoconstrictor infusion in young rats. J Cardiovasc Pharmacol 1993, 22:388-395.
67. Schiffrin EL, Larivière R, Li J-S, Sventek P, Touyz RM: Deoxycorticosterone acetate plus salt induce overexpression of vascular endothelin-1 and severe vascular hypertrophy in spontaneously hypertensive rats. Hypertension 1995, 25: 769-773.
68. Li J-S, Larivière R, Schiffrin EL: Effect of a non selective endothelin antagonist on vascular remodelling in DOCA-salt hypertensive rats. Hypertension 1994, 24:183-188.
69. Li J-S, Schiffrin EL: Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist. Hypertension 1995, 25:495-500.
70. Schiffrin EL, Larivière R, Li J-S, Sventek P: Enhanced expression of endothelin-1 gene in DOCA-salt hypertensive rats: correlation with vascular structure. J Vasc Res 1996, 33:235-248.
71. Lew JM, Angus JA: Wall thickness to lumen diameter ratios of arteries from SHR and WKY: comparison of pressurised and wire-mounted preparations. J Vasc Res 1992, 29:435-442.
72. Lee RMKW, Berecek KH, Tsoporis J, McKenzie R, Triggle CR: Prevention of hypertension and vascular changes by captopril treatment. Hypertension 1991, 17:141-150.
73. Hajdu MA, Heistad DD, Baumbach GL: Effects of antihypertensive therapy on mechanics of cerebral arterioles in rats. Hypertension 1991, 17:308-316.
74. Falloon BJ, Stephens N, Tulip JR, Heagerty AM: Comparison of small artery sensitivity and morphology in pressurized and wire-mounted preparations. Am J Physiol 1995, 268:H670-H678.
75. Osol G, Halpern W: Myogenic properties of cerebral blood vessels from normotensive and hypertensive rats. Am J Physiol 1985, 249:H914-H921.
76. Osol G, Halpern W: Spontaneous vasomotion in pressurized cerebral arteries from genetically hypertensive rats. Am J Physiol 1988, 254:H28-H33.
77. Tesfamarian B, Halpern W: Endothelium-dependent and endothelium-independent vasodilation in resistance arteries from hypertensive rats. Hypertension 1988, 11:440-444.
78. Dohi Y, Lüscher TF: Endothelin in hypertensive resistance arteries: intraluminal and extraluminal dysfunction. Hypertension 1991, 18:543-549.
79. Falloon BJ, Bund SJ, Tulip JR, Heagerty AM: In vitro perfusion studies of resistance artery function in genetic hypertension. Hypertension 1993, 22:486-495.
80. Falloon BJ, Heagerty AM: In vitro perfusion studies of function of human resistance arteries in essential hypertension. Hypertension 1994, 14:16-23.
81. Buus NH, VanBavel E, Mulvany MJ: Differences in sensitivity of rat mesenteric small arteries to agonists when studied as ring preparations or as cannulated preparations. Br J Pharmacol 1994, 112:579-587.
82. Laurant PM, Touyz RM, Schiffrin EL: Effect of pressurization on mechanical properties of perfused mesenteric small arteries from spontaneously hypertensive rats. J Vasc Res 1997, in press.
83. Deng LY, Li J-S, Schiffrin EL: Endothelium-dependent relaxation of small arteries from essential hypertensive patients. Clin Sci 1995, 88:611-622.
84. Panza JA, Arshed A, Brush JE Jr, Epstein SE: Abnormal endothelium dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990, 323:22-27.
85. Imig JD, Anderson GL: Small artery resistance increases during the development of renal hypertension. Hypertension 1991, 17:317-322.
86. Mulvany MJ: A reduced elastic modulus of vascular wall components in hypertension? Hypertension 1992, 20:7-9.
87. Dickhout JG, Lee RMKW: Structural and functional analysis of small muscular arteries from prehypertensive spontaneously hypertensive rats. Hypertension 1997, 29:781-789.
88. Post MJ, Borst C, Kuntz RE: The relative importance of arterial remodeling compared with intimai hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan micropig. Circulation 1994, 89:2816-2821.
89. Arndt JO, Klauske J, Mersch F: The diameter of intact carotid artery in man and its change with pulse pressure. Pflügers Arch 1968, 301:230-240.
90. Hokanson DE, Mosersky DJ, Sumner DS: A phased-locked echo tracking system for recording arterial diameter changes in vivo. J Appl Physiol 1972, 32:728-733.
91. Tardy Y, Meister JJ, Perret F, Brunner HR, Arditi M: Noninvasive estimate of the mechanical properties of peripheral arteries from ultrasonic and photoplethysmographic measurements. Clin Phys Physiol Meas 1991, 12:39-54.
92. Hayoz D, Tardy Y, Rutschmann B, Mignot JP, Achakri H, Feihl F, et al.: Noninvasive measurements of spontaneous conduit vessel diameter oscillation. Am J Physiol 1993, 264:H2080-H2084.
93. Pignoli P: Ultrasound B-mode imaging for arterial wall thickness measurement. Ultrasound Med Biol 1989, 15:177-184.
94. Tardy Y, Hayoz D, Mignot JP, Richard P, Brunner HR, Meister JJ: Noninvasive measurement of arterial diameter and wall thickness with ultrasound. J Hypertens 1992, 10 (suppl 6): S105-S109.
95. Demoment G, Reynaud R, Herment A: Range resolution improvement by fast deconvolution method. Ultrasonic Imaging 1984, 6: 435-451.
96. Girerd X, Mourad JJ, Acar C, Heudes D, Chiche S, Bruneval P, et al.: Noninvasive measurement of medium-sized artery intima-media thickness in humans: in vitro validation. J Vasc Res 1994, 31:114-120.
97. Weber R, Stergiopulos N, Brunner HR, Hayoz D: Contribution of vascular tone and structure to elastic properties of a medium size artery. Hypertension 1996, 27:816-822.
98. Hoeks APG, Brands PJ, Smeets FAM, Reneman RS: Assessment of distensibility of superficial arteries. Ultrasound Med Biol 1990, 16:121-128.
99. Wesseling KH, Seffels JJ, De Wit B: The measurements of continuous finger arterial pressure non-invasively in stationary subjects. In Biological and Physiological Factors in Cardiovascular Disease. Edited by Schmidt T, Dembroski T, Blumchen G, Berlin: Springer-Verlag; 1986:355-375.
100. Parati G, Casadei R, Groppelli A, Di Rienzo M, Mancia G: Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing. Hypertension 1989, 13:647-655.
101. Hayoz D, Drexler H, Munzel T, Hornig B, Zeiher AM, Just H, et al. Flow mediated arterial dilation is abnormal in congestive failure. Circulation 1993, 87 (suppl VII):VII92-VII96.
102. Drexler H, Hayoz D, Münzel T, Hornig B, Just H, Brunner HR, et al.: Endothelial function in congestive heart failure. Am J Cardiol 1992, 69:1596-1601.
103. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuilliez C, et al.: Nitric oxide is responsible for flow-dependent dilation of human peripheral conduit arteries in vivo. Circulation 1995, 91:1314-1319.
104. Laurent S, Hayoz D, Trazzi S, Boutouyrie P, Waeber B, Omboni S, et al.: Isobaric compliance and distensibility of the radial artery is increased in patients with essential hypertension. J Hypertens 1993, 11:89-98.
105. Laurent S, Girerd X, Mourad JJ, Lacolley P, Beck L, Boutouyrie P, et al.: Elastic modulus of the radial artery wall material is not increased in patients with essential hypertension. Arterioscler Thromb 1994, 14:1223-1231.
106. Gariepy J, Massonneau M, Levenson J, Heudes D, Simon A: Evidence for in vivo carotid and femoral wall thickening in human hypertension. Hypertension 1993, 22:111-118.
107. Roman MJ, Saba PS, Pini R, Spitzer M, Pickering TG, Rosen S, et al.: Parallel cardiac and vascular adaptation in hypertension. Circulation 1992, 86:1909-1918.
108. Girerd X, Mourad JJ, Copie X, Moulin C, Acar C, Safar M, et al.: Noninvasive detection of an increased vascular mass in untreated hypertensive patients. Am J Hypertens 1994, 7:1076-1084.
109. Ganau A, Devereux RB, Roman MJ, de Simone G, Picketing TG, Saba PS, et al.: Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992, 19:1550-1558.
110. Giannattasio C, Failla M, Stella ML, Mangoni AA, Carugo S, Pozzi M, et al.: Alteration of radial artery compliance in patients with congestive heart failure. Am J Cardiol 1995, 76:381-385.
111. Grassi G, Giannattasio C, Failla M, Pesenti A, Peretti G, Marinoni E, et al.: Sympathetic modulation of radial artery compliance in congestive heart failure. Hypertension 1995, 26:348-354.
112. Girerd X, Giannattasio C, Moulin C, Safar M, Laurent S: Regression of radial artery wall hypertrophy and improvement of carotid artery compliance after long term antihypertensive treatment [abstract]: the Pericles study. Seventh European Meeting on Hypertension, Milan. Milan: University of Milan; 1995.